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A female spayed, 7-year-old Doberman dog was presented to the ophthalmologist with a palpebral 16 
nodule on the haired eyelid of the left eye. The nodule was surgically removed and submitted for 17 
histopathology. Histologically, the nodule was consistent with eyelid melanocytoma. The neoplasia 18 
was also characterized by an unusual histological feature: interspersed throughout the neoplastic 19 
melanocytes, numerous lacunar and slit-like spaces filled by erythrocytes were observed. On 20 
immunohistochemistry, these spaces were lined by cells PNL2-positive and Factor VIII and CD31 21 
negative, consistent with neoplastic melanocytes without endothelial cell participation. This feature 22 
was interpreted as vasculogenic mimicry (VM), a mechanism of tumour angiogenesis well-23 
recognized in human melanomas that, to the authors’ best knowledge, has not yet been reported in 24 
melanomas in veterinary medicine.  25 
 26 
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Vasculogenic mimicry (VM) is a well-known feature of human melanoma (Maniotis et al., 1999). 28 
VM has been defined as the de novo generation of vascular channels by tumour cells and is not 29 
considered a strictly vasculogenic event because it does not result in de novo formation of 30 
endothelial cell-lined vessels (Spiliopoulos et al., 2015). Rather, these microcirculatory networks or 31 
capillary-like structures are made of extracellular matrix and are lined by neoplastic cells instead of 32 
endothelium (Spiliopoulos et al., 2015). It is still not well understood if these vascular structures are 33 
functional, however these channels can be detected angiographically and red blood cells are 34 
histologically recognizable within their lumens (Maniotis et el., 1999). Lining endothelial cells have 35 
not been identified by light microscopy, by transmission electron microscopy, or by the use of 36 
immunohistochemical endothelial cell markers (Factor VIII-related antigen, CD31, CD34, and 37 
KDR[Flk-1]) (Maniotis et el., 1999; Spiliopoulos et al., 2015). 38 
VM was firstly described in human melanoma by Maniotis and coauthors in 1999 (Maniotis et el., 39 
1999) and, thereafter, it has also been reported in different types of human tumour, such as 40 
malignant mesothelioma (Pulford et al., 2016), cancer of the liver (Zhao et al., 2015), pancreas 41 
(Guo et al., 2014), stomach (Zang et al., 2015), prostate (Wang et al., 2016), ovaries and breast 42 
(Hendrix et al., 2003). The presence of VM patterns in patients with malignant tumours, e.g. human 43 
uveal and cutaneous melanomas, has been correlated with a worse prognosis and shorter survival 44 
than their non-VM-forming counterparts (Spiliopoulos et al., 2015).  45 
To date, in dogs, VM has been reported only in canine inflammatory breast cancer (Clemente et al., 46 
2010; Rasotto et al., 2012) but, to the best of the authors’ knowledge, it has not been previously 47 
described in canine melanocytic tumours. In the present report, VM pattern is described in a 48 
melanocytic neoplasm of the eyelid in a dog. 49 
A female spayed Doberman 7-year old dog was presented with a 5 mm, brownish, palpebral nodule 50 
on the skin of the upper eyelid of the left eye. The nodule had been present for one year and was 51 
slowly enlarging. Complete ophthalmic examination was otherwise unremarkable, except for mild 52 
bilateral epiphora. Pre-operative diagnostic tests, i.e. complete blood count and serum chemistry, 53 
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were within normal limits. The nodule was surgically removed with “V" full-thickness excision and 54 
submitted for histopathology. The sample was fixed in 10% buffered formalin and routinely 55 
processed for histology. Microtomic section were obtained and stained with hematoxylin and eosin 56 
(H&E) for histopathological examination.  57 
Histologically, the dermis of the eyelid was expanded by a multilobular nodular neoplasm, which 58 
was moderately well demarcated and not encapsulated. Neoplastic cells were arranged in lobules 59 
and nests with multifocal areas of junctional activity. Neoplastic cells were epithelioid or, less 60 
commonly, spindle-shaped, with indistinct cell borders and high nucleus/cytoplasmic ratio. 61 
Cytoplasm was moderate, granular and eosinophilic, occasionally vacuolated and multifocally filled 62 
by melanin pigment. Nuclei were oval, with marginated chromatin and single prominent central 63 
nucleolus. Anisocytosis and anisokaryosis were moderate and mitotic count in 10 HPF was 1. 64 
Multifocally, throughout the neoplasm, numerous irregular slit-like or lacunar spaces were observed 65 
(Figure 1). These spaces were filled by a moderate number of red blood cells, were supported by 66 
fine fibrous stroma and were lined by polygonal, epithelioid or spindle cells with moderate 67 
cytoplasm and a round to oval nucleus with a prominent nucleolus. The neoplasm was diagnosed as 68 
a mixed-type sparsely pigmented dermal melanocytoma, .  69 
With Periodic acid–Schiff (PAS) special staining of serial sections, performed to characterize the 70 
lacunar spaces, there was moderately positive staining of the thin fibrous septa delimiting the blood-71 
filled spaces.  72 
Immunohistochemistry (ABC standard method) was also performed to further characterize the cells 73 
lining the blood-filled lacunar spaces. The endothelial cell markers Factor VIII (FVIII) and CD31 74 
and the melanocytic marker PNL2 were specifically investigated.  75 
For immunohistochemistry, serial microtomic sections were obtained and mounted on polylysine 76 
coated slides (Menzel-Gläser, Braunschweig, Germany). PNL and FVIII labelling were performed 77 
by manual staining with standard ABC method. After heat-induced antigen retrieval in EDTA 78 
buffer (PNL2) or enzymatic-retrieval with pepsin (FVIII), slides were immunostained using a 79 
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mouse monoclonal anti-PNL2 antibody (Monosan, Uden, Netherlands), incubated at 1:25 overnight 80 
at 4°C, and a rabbit polyclonal anti-Factor VIII antibody (Dako, Carpinteria, USA), incubated at 81 
1:200 overnight at 4°C, respectively. CD31 labelling was automatically performed with 82 
Ventana BenchMarck ULTRA (Ventana Medical System, Roche, Oro Valley, AZ, USA): the 83 
sections were unmasked with Benchmark ULTRA CC1 (pH 8.4) at 95°C for 52 minutes and 84 
incubated with the primary antibody mouse monoclonal anti-CD31 Endothelial cell (JC70A; Dako, 85 
Carpinteria, USA), at 1:20 for 32 minutes at room temperature. DAB (3,3’-diaminobenzidine) 86 
(Roche, Oro Valley, AZ, USA ) or AEC (3-amino-9-ethylcarbazole) (Vector Laboratories, 87 
Burlingame, USA) substrate-chromogen kit were used as chromogen, and sections were 88 
counterstained with Mayer’s hematoxylin. Negative controls were prepared by replacing the 89 
respective primary antibody with normal rabbit or mouse serum (non-immune serum, 90 
Dakocytomation). Endothelium of blood vessels served as internal positive control for FVIII and 91 
CD31.  92 
The cells lining red blood cell-filled spaces, as well as the neoplastic cells composing the 93 
melanocytoma, labelled strongly with antibody against PNL2 (Figure 2), whereas they were 94 
negative to FVIII and CD31 (Figures 3-4). Normal endothelium of pre-existing blood vessels within 95 
the same section was diffusely and intensely stained with both FVIII and CD31.  96 
Based on histological and immunohistochemical results, lacunar spaces were interpreted as areas of 97 
vasculogenic mimicry within an eyelid melanocytoma.  98 
Eight months after surgery, the dog was in good health conditions with no indications of recurrence 99 
of the eyelid mass.  100 
The term vasculogenic mimicry (VM) has been used to describe the ability of aggressive neoplastic 101 
cells to acquire an endothelial-like morphology and to form extracellular matrix (ECM)-rich 102 
vasculogenic-like networks (Hendrix et al., 2003), which are hypothesized to facilitate tumour 103 
perfusion independently from tumour angiogenesis (Maniotis et al., 1999). The present case 104 
describes histological evidences of vasculogenic mimicry in a canine cutaneous melanocytoma. The 105 
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mass arose on the eyelid and contained widespread microscopic slit-like and lacunar spaces filled 106 
with erythrocytes. Histochemical and immunohistochemical staining confirmed the melanocytic 107 
origin of the cells lining these lacunar spaces. In fact, these spaces, sustained by PAS-positive 108 
fibrous septa, were lined by cells that labelled strongly with antibody against PNL2, marker of 109 
melanocytic origin, whereas did not label with antibodies anti FVIII and CD31, markers of 110 
endothelial origin. These results confirmed the melanocytic origin of the cells lining the newly 111 
formed vascular network and confirmed the presence of a “vasculogenic mimicry” phenomenon.  112 
In VM in human melanoma, it has now been recognized that the deeper layer of melanoma cell-113 
lined microvascular structures is composed of extracellular matrix proteins such as laminin, 114 
collagens IV and VI, and heparan sulfate proteoglycans, which provide the PAS-positive supportive 115 
fibrous stroma (Spiliopoulos et al., 2015). Currently, there are two hypotheses concerning the origin 116 
of VM network-forming melanoma cells: they could either be tumour cells that have undergone de-117 
differentiation, resulting in a primitive cell-type which encompasses tumour cell, stem cell, and 118 
endothelial cell characteristics, or they may arise from cancer stem cells (Spiliopoulos et al., 2015). 119 
VM in melanoma involves several signaling molecules that are also involved in embryonic 120 
vasculogenesis, including for example vascular endothelial (VE)-cadherin, erythropoietin-121 
producing hepatocellular carcinoma-A2 (EPHA2), phosphatidylinositol 3-kinase, focal adhesion 122 
kinase, matrix metalloproteinases and laminin 5 γ2-chain (Hendrix et al., 2003). Identification of 123 
the pathways that regulate this undifferentiated and highly plastic phenotype may be strategic in the 124 
development of new therapies for human cancer. In fact, even though the biological implications of 125 
VM in vivo are still unclear, tumour VM is associated with a poor prognosis (Hendrix et al., 2016). 126 
Thus, VM in tumours of human patients with a poor clinical outcome suggests a functionally 127 
relevant role in the survival of tumour cells (Hendrix et al., 2016). VM in human melanomas is 128 
correlated with a high mitotic index and prevalence of epithelioid morphology, which is associated 129 
with worse prognosis (Spiliopoulos et al., 2017).  130 
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Nevertheless, VM has also been described in benign melanocytic nevi (Demitsu et al., 1998; 131 
Spiliopoulos et al., 2017). In a study by Spiliopoulos and co-authors on human melanocytic tumours 132 
of the eye and the periocular area, 10% of benign nevi, mostly arising in the conjunctiva, included 133 
areas of VM, without any other atypical features, suggesting the absence of an association with 134 
malignant potential. However, in human medicine, conjunctival nevi can occasionally also behave 135 
as pre-cancerous lesions and progress into melanomas. The prognostic implication of VM in benign 136 
nevi has not yet been elucidated (Spiliopoulos et al., 2017).   137 
There are few reports in the veterinary literature of VM in dogs. VM has been reported in canine 138 
mammary carcinoma: specifically, VM has a higher frequency in inflammatory mammary cancer 139 
compared to non-inflammatory mammary cancer (Clemente et al., 2010), although VM is not 140 
considered predictive of invasion of the lymphatic system (Rasotto et al., 2012).  141 
To the best of the authors’ knowledge, VM has not been previously reported in canine melanocytic 142 
tumours. To date, there are insufficient cases in the veterinary literature on VM in canine 143 
melanocytic tumours to draw prognostic considerations on the significance of VM in dogs, yet it 144 
would be interesting to assess if this phenomenon may bear a role in the behavior and invasiveness 145 
of this tumour, thus resembling the human cases. The incidence, role and prognostic significance of 146 
VM in veterinary species is a field worthy of further investigation.  147 
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Figure legends 193 
 194 
Fig. 1. Dermis is expanded by a multilobular melanocytoma admixed with numerous irregular slit-195 
like or lacunar spaces filled by red blood cells. H&E, bar = 25 μm.  196 
Fig. 2. Spaces are lined by PNL2-positive neoplastic cells. IHC anti-PNL2, AEC chromogen, bar = 197 
12.5 μm.  198 
Fig. 3. Cells lining blood-filled spaces are FVIII negative. IHC anti-FVIII, AEC chromogen, bar = 199 
12,5 μm.  200 
Fig. 4. Cells lining blood-filled spaces are CD31 negative. IHC anti-CD31, DAB chromogen, bar = 201 
12,5 μm.  202 
